Abcam, ab314303, Anti-Renalase antibody [EPR25655-163]

Size: 20µL / 100µL / 1mL
Rabbit Recombinant Monoclonal Renalase antibody. Suitable for WB, IP and reacts with Human samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR25655-163,
Isotype:IgG,
Carrier free:No,
Reacts with:Human,
Applications:IP, WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Preservative: 0.01% Sodium azideConstituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, Shipped at conditions-Blue Ice, Appropriate short-term storage duration-1-2 weeks, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Renalase also known as RNLS is a flavoprotein that catalyzes the oxidation of catecholamines such as dopamine and norepinephrine. It has a mass of approximately 37 kDa. The protein is expressed in the kidney heart and other tissues including the liver and brain. Its enzymatic activity helps in regulating blood pressure and cardiac function by metabolizing circulating monoamines.
Biological function summary
Renalase impacts the cardiovascular system through its enzymatic function that reduces systemic catecholamine levels. It has been shown the protein interacts with catecholamines beyond the boundaries of a simple enzymatic reaction. Renalase may form complexes with other enzymes that participate in detoxifying catecholamines. Researchers have studied its effects on catecholamine-related stress responses highlighting a potential modulatory function beyond simple substrate degradation.
Pathways
The metabolism of catecholamines involves Renalase in the regulation of the sympathetic nervous system and its associated pathways. Renalase fits into the catecholamine degradation pathway where it works alongside other enzymes such as monoamine oxidase which also breaks down neurotransmitters. These actions influence the broader systemic pathways associated with cardiovascular health by maintaining a balance in neurotransmitter levels and resultant blood pressure regulation.
Renalase has been associated with hypertension due to its role in catecholamine metabolism. Abnormal Renalase function can contribute to increased circulating catecholamines leading to elevated blood pressure. Additionally studies have suggested a link between Renalase and chronic kidney disease where alterations in Renalase activity may exacerbate kidney dysfunction. The relationship between Renalase and proteins like angiotensin-converting enzyme (ACE) further hints at its potential involvement in blood pressure regulation and renal pathology.